US Stocks
/
Atossa Therapeutics, Inc. Share Price

Atossa Therapeutics, Inc. Share Price

NASDAQ: ATOS | Micro Cap
$2.38
+$0.08 (3.48%) Last updated on 11 Aug, 2026 | 01:28 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Atossa Therapeutics, Inc. Stock Performance

Open
$2.33
Prev. Close
$2.30
Circuit Range
N/A
Day Range
$2.33 - $2.44
Year Range
$0.53 - $7.50
Volume
1,584
Average Traded
$2.40

Atossa Therapeutics, Inc. Share Price Today

As of 11 August 2026, Atossa Therapeutics, Inc.'s share price is $2.38. The stock opened at $2.33, compared to its previous close of $2.30. During today's trading session, Atossa Therapeutics, Inc.'s share price traded between $2.33 and $2.44, with an average price of $2.39. Over the past 52 weeks, the stock has recorded a high of $7.50 and a low of $0.53. In terms of performance, Atossa Therapeutics, Inc.'s share price has declined by 45.41% over the last six months and is up 211.52% on a year-on-year basis.

Atossa Therapeutics, Inc. Share Price Chart

$2.33$2.44
L
Show Current Price
H

Atossa Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$20.49M
PE Ratio (TTM)
-0.59
Dividend Yield
N/A
EPS (TTM)
$-4.04
Revenue (TTM)
N/A
Return On Equity (TTM)
-88.35%
Profit Margin
N/A
Debt to Equity
0.21
Quarterly Earnings Growth YoY
-20.22%

Atossa Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
RevenueN/AN/AN/AN/AN/AN/A
Net Profit-$5.88M-$6.05M-$7.23M-$6.72M-$8.42M-$8.69M
Net Profit MarginN/AN/AN/AN/AN/AN/A
Income ChangeN/A-2.91%-19.52%7.08%-25.38%-3.19%

Atossa Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars20212022202320242025
RevenueN/AN/AN/AN/AN/A
Net Profit-$20.61M-$26.96M-$30.09M-$25.50M-$34.77M
Net Profit MarginN/AN/AN/AN/AN/A
Income ChangeN/A-30.84%-11.62%15.25%-36.33%

About Atossa Therapeutics, Inc.

Atossa Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States. The company's lead drug candidate is oral (Z)-endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It also develops immunotherapy/chimeric antigen receptor therapy programs. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is based in Seattle, Washington.

Atossa Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Aug 2026
$2.14
$2.30
+12.20%
Jul 2026
$1.94
$2.05
+5.94%
Jun 2026
$5.17
$1.94
-62.61%
May 2026
$5.87
$5.17
-4.70%
Apr 2026
$5.25
$5.43
+7.21%
Mar 2026
$4.30
$5.07
+16.17%
Feb 2026
$6.93
$4.36
+673.05%
Jan 2026
$0.60
$0.56
-3.42%
Dec 2025
$0.77
$0.58
-24.94%
Nov 2025
$0.89
$0.78
-12.39%
Oct 2025
$0.88
$0.89
+2.30%
Sep 2025
$0.77
$0.87
+13.61%

ATOS Share Price FAQs

What is Atossa Therapeutics, Inc. share price today?

chevron-up
Atossa Therapeutics, Inc. share price today is $2.38 as on August 11, 2026 at 1:28 am IST.

What is the 52 week high and 52 week low of Atossa Therapeutics, Inc. stock?

chevron-up
The 52 week high of Atossa Therapeutics, Inc. stock is $7.50, while the 52 week low is $0.53 as of 11 Aug '26.

What is ATOS's market capitalisation today?

chevron-up
ATOS market capitalisation is $20.49M as of August 11, 2026, at 6:52 pm IST.

What is ATOS's net income for the last quarter?

chevron-up
ATOS's net income for the last quarter is -0.01B USD.

What is the 5 year returns of ATOS?

chevron-up
The 5 year returns of ATOS is -37.45% as on 11 Aug '26.

What is the high & low stock price of ATOS today?

chevron-up
ATOS stock price hit a high of $2.44 and low of $2.33 as of 11 Aug '26.

Can I buy ATOS shares in India?

chevron-up
Yes. You can buy ATOS in India by opening an international trading account.